.jpg)
64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing
SAN FRANCISCO–(Business enterprise WIRE)–64x Bio, a artificial biology enterprise, right now declared the shut of
64x
SAN FRANCISCO–(Business enterprise WIRE)–64x Bio, a artificial biology enterprise, right now declared the shut of